Latest Medivir News & Updates

See the latest news and media coverage for Medivir. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Medivir

Drug discovery and development company

medivir.com
Headquarters
Huddinge, Sweden
Founded year
1988
Company type
Public company
Number of employees
2–50

Latest news about Medivir

Company announcements

  • Medivir

    Medivir summons shareholders to AGM

    The meeting occurs on 7 May 2026 in Stockholm, with proposals for board elections, remuneration, share issue authorization, and a board incentive program.

  • Medivir

    Medivir publishes 2025 Annual Report

    The report highlights transformative 2025 achievements including fostrox study results, MIV-711 Orphan Drug Designation, funding via rights and share issues, and licensing deals. It announces planned Phase 2 studies.

  • Medivir

    Medivir creates Scientific Expert Council for MIV-711 in Osteogenesis Imperfecta

    The council comprises world-leading OI specialists to guide clinical study design and execution. MIV-711 received FDA Orphan Drug Designation.

  • Medivir

    Medivir updates clinical programs

    CEO Jens Lindberg presents at DNB Carnegie Healthcare Seminar on MIV-711 for Osteogenesis Imperfecta and fostrox for liver cancer.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Medivir

Track Medivir and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Medivir competitors & trending companies

Browse news for competitors to Medivir and other trending companies.